A 2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist as a 5-HT3-receptor antagonist

摘要

The present invention relates to a novel 5HT₃-5-chloro-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acid-octahydro-3-hydroxy-2,6-methano-2H-Quinolizin-8-yl ester, a process for the preparation thereof, and a method for the treatment of nausea and vomiting induced by radiotherapy and chemotherapy, for the treatment of pain associated with migraine, for treatment of cognitive disorders, for patients of schizophrenia and mania To the treatment of endogenous psychosis, to the treatment of excitatory bowel syndrome and to the use thereof in the treatment of substance abuse.